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Triple cysteine module within M-type K+ channels mediates reciprocal
channel modulation by nitric oxide and reactive oxygen species
Abstract
We have identified a new signaling role for nitric oxide (NO) in neurons from the trigeminal ganglia (TG). We
show that in rat sensory neurons from the TG the NO donor, S-nitroso-N-acetyl-dl-penicillamine, inhibited
M-current. This inhibitory effect was blocked by NO scavenging, while inhibition of NO synthases increased
M-current, suggesting that tonic NO levels inhibit M-current in TG neurons. Moreover NO increased
neuronal excitability and calcitonin gene-related peptide (CGRP) release and these effects could be prevented
by perturbing M-channel function. First, NO-induced depolarization was prevented by pre-application of the
M-channel blocker XE991 and second, NO-induced increase in CGRP release was prevented by incubation
with the M-channel opener retigabine. We investigated the mechanism of the effects of NO on M-channels
and identified a site of action of NO to be the redox modulatory site at the triplet of cysteines within the
cytosolic linker between transmembrane domains 2 and 3, which is also a site of oxidative modification of M-
channels by reactive oxygen species (ROS). NO and oxidative modifications have opposing effects on M-
current, suggesting that a tightly controlled local redox and NO environment will exert fine control over M-
channel activity and thus neuronal excitability. Together our data have identified a dynamic redox sensor
within neuronal M-channels, which mediates reciprocal regulation of channel activity by NO and ROS. This
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Brief Communications
Triple Cysteine Module within M-Type K Channels
Mediates Reciprocal Channel Modulation by Nitric Oxide
and Reactive Oxygen Species
Lezanne Ooi,1,2 Sylvain Gigout,1 Louisa Pettinger,1 and Nikita Gamper1
1Faculty of Biological Sciences, School of Biomedical Sciences, University of Leeds, Leeds, LS2 9JT, United Kingdom and 2Illawarra Health and Medical
Research Institute, School of Biological Sciences, University of Wollongong, Northfields Avenue, Wollongong, New South Wales 2522, Australia
We have identified a new signaling role for nitric oxide (NO) in neurons from the trigeminal ganglia (TG). We show that in rat sensory
neurons from the TG the NO donor, S-nitroso-N-acetyl-DL-penicillamine, inhibited M-current. This inhibitory effect was blocked by NO
scavenging, while inhibition of NO synthases increased M-current, suggesting that tonic NO levels inhibit M-current in TG neurons.
Moreover NO increased neuronal excitability and calcitonin gene-related peptide (CGRP) release and these effects could be prevented by
perturbing M-channel function. First, NO-induced depolarization was prevented by pre-application of the M-channel blocker XE991 and
second, NO-induced increase in CGRP release was prevented by incubation with the M-channel opener retigabine. We investigated the
mechanism of the effects of NO on M-channels and identified a site of action of NO to be the redox modulatory site at the triplet of cysteines
within the cytosolic linker between transmembrane domains 2 and 3, which is also a site of oxidative modification of M-channels by
reactive oxygen species (ROS). NO and oxidative modifications have opposing effects on M-current, suggesting that a tightly controlled
local redox and NO environment will exert fine control over M-channel activity and thus neuronal excitability. Together our data have
identified a dynamic redox sensor within neuronal M-channels, which mediates reciprocal regulation of channel activity by NO and ROS.
This sensor may play an important role in mediating excitatory effects of NO in such trigeminal disorders as headache and migraine.
Introduction
Nitric oxide (NO) is a molecular mediator with diverse physio-
logical roles, including blood pressure regulation, clotting, and
nociception. Within the somatosensory system NO is released
from dural mast cells and nerve fibers following inflammation
and contributes to pain (Berger et al., 1994). The cell bodies of
sensory neurons that innervate the face and head reside in the
trigeminal ganglia (TG); increased excitability of TG neurons is
interpreted as pain and in this way NO can induce delayed head-
aches in migraine sufferers (Akerman et al., 2002). A role for
calcitonin gene-related peptide (CGRP), released from trigemi-
nal afferents, has also been implicated in migraine pain. CGRP
levels are higher in the plasma of migraine sufferers compared
with controls (Ashina et al., 2000) and during migraine attacks
activation of trigeminal sensory fibers causes CGRP release
(Goadsby et al., 1990). Experimentally migraines can be induced
by NO donors (Thomsen et al., 1993) and reduced with CGRP
antagonists (Wei et al., 1992). Further evidence links these signal-
ing molecules as NO promotes the release of CGRP from afferent
fibers (Messlinger et al., 2000). However NO-mediated increases
in CGRP are not caused by increases in CGRP mRNA (Eberhardt
et al., 2009) and a mechanism for increased trigeminal neuronal
activity has yet to be identified.
Expression of M-type K channels (encoded by KCNQ genes)
in sensory ganglia limits neuronal excitability, exerting an anti-
nociceptive effect (Passmore et al., 2003). Accordingly, inhibition
of M-current via pro-inflammatory Gq-protein-coupled recep-
tors (Gq-PCRs) contributes to peripheral sensitization and in-
flammatory pain (Linley et al., 2008; Liu et al., 2010). A triple
cysteine pocket within neuronal M-channel subunits (Kv7.2–7.5)
can be oxidatively modified by H2O2 (Gamper et al., 2006) and
O2
 (Linley et al., 2012a) both causing augmentation of
M-current. Here we have identified a reactive redox module
within M-channels that is responsible for dynamic M-current
modulation by gasotransmitters and contributes to NO-induced
increased excitability in trigeminal neurons.
Materials and Methods
Compounds. NO formation from S-nitroso-N-acetyl-DL-penicillamine
(SNAP; Sigma-Aldrich) is linear (100 M yields 1.4 M NO/min). Reti-
gabine (RTG; a gift from Professor Hailin Zhang, Hebei Medical Univer-
sity, People’s Republic of China) is a specific M-channel opener,
enhancing currents of Kv7.2–7.5 (EC50 2–5 M; Tatulian et al., 2001).
XE991 (Tocris Bioscience) is a selective M-channel blocker (IC50 0.3 M;
Passmore et al., 2003). At higher concentrations XE991 blocks HERG
channels (IC50 100 M; Elmedyb et al., 2007); however, at the concentra-
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tion used in this study (3 M) it is M-channel
selective. LNitroarginine (L-NNA) (Cayman)
is a competitive inhibitor of nitric oxide syn-
thase (NOS) [Ki values in the nanomolar range
for the neuronal (nNOS) and endothelial
(eNOS) isoforms and in the micromolar range
for inducible (iNOS); Furfine et al., 1993].
Carboxy-PTIO (Cayman) reacts with NO, in-
hibiting S-nitrosation (IC50 100 M; Pfeiffer et
al., 1997).
Cell cultures and transfections. TG from P7
rats of either sex were removed and dissociated
and neurons and Chinese hamster ovary
(CHO) cells were cultured according to the
methods described previously (Linley et al.,
2008). Plasmids encoding human Kv7.4 wild-
type and mutant (CCC156 –158AAA) were a
gift from Professor Mark Shapiro (University
of Texas Health Science Center at San Antonio,
San Antonio, Texas). All experimental proce-
dures were approved by and in compliance
with the University of Leeds ethical review
committee.
Electrophysiology. Recordings were performed
as described previously (Linley et al., 2012a). In
TG neurons M-current amplitude was measured
from the deactivation current (Ideac) elicited by a
500 ms square voltage pulse to 60 mV from a
holding potential of 30 mV. M-current was
quantitated as the XE991-sensitive Ideac. CHO
cells expressing M-channels were held at 0 mV
with 500 ms steps to 60 mV and 600 ms pulses
back to 0 mV with 3 s intervals. The amplitude of
the current was defined as the XE991-sensitive
current at 0 mV (I0). Current-clamp recordings
were performed using current injections (be-
tween 0.5 and 1 nA, increment 0.025 nA, du-
ration 600 ms, interval 5 s). Linear regression of
the number of action potentials (APs) versus in-
jected current (nA) in the initial linear range was
used to calculate the slope of neuronal firing. This
parameter provides a quantitative excitability in-
dex describing the dependence of action poten-
tial firing frequency on the amplitude of injected
current.
Biotin switch assay and Western blot. CHO cells
were transfected with pcDNA3.1 encoding myc-
tagged Kv7.4 wild-type, CCC156–158AAA mu-
tant or a transfection control (pmaxGFP). The
biotin switch assay to visualize S-nitrosylated
proteins was performed as in (Jaffrey and Snyder,
2001), in which S-nitrosylated cysteines were la-
beled with biotin. Protein samples were immu-
noprecipitated with anti-biotin-labeled protein
G Dynabeads (Invitrogen), following the manu-
facturer’s protocol. Protein extracts (20 g) in
nonreducing sample buffer (10 mM Tris-HCl, pH
6.8, 10% glycerol, 0.02% bromophenol blue)
were separated through 8% native polyacryl-
amide gels. Proteins were transferred to mem-
branes and screened with anti-myc antibody
(Santa Cruz Biotechnology; 1:1000) in PBS, 0.1% Tween 20, 5% milk pow-
der, followed by 1:2000 secondary horseradish peroxidase-conjugated anti-
mouse antibody. For the denaturing Western blot, input proteins (collected
from the same samples before immunoprecipitation) were boiled for 10 min
in SDS sample buffer (as above plus 4% SDS, 200 mM dithiothreitol; DTT),
separated on polyacrylamide gels and blotted as above.
CGRP release assay. To determine basal release levels, TG cultures were
incubated at 37°C for 10 min in 500 l of standard bathing solution (SBS).
Cells were incubated with a further 500 l of SBS in the presence or absence
of RTG (10 M) for 10 min at 37°C, followed by incubation with or without
SNAP (100 M) for 20 min. SBS was replaced with either SNAP alone or
SNAP and RTG for a further 10 min. The SBS was collected and CGRP
release was measured according to the manufacturer’s instructions (SPBio).
Statistics. All data are given as mean  SEM. Differences between
groups were assessed by Student’s t test or one-way ANOVA with Bon-
ferroni post hoc test.
Figure 1. NO inhibits M-current and increases neuronal excitability. A, Exemplary perforated patch voltage-clamp recording
from a TG neuron. The magnitude of the deactivating tail current (Ideac) when stepping from 30 to 60 mV was plotted against
time. Bath application of SNAP (1 mM) and the M-channel inhibitor XE991 (3 M) is indicated by the black bars. The voltage protocol
and exemplary current traces are also shown. B, Mean data from experiments as in A, expressed as percentage change in M-current
from basal (n  12). C, Concentration dependence of SNAP-induced M-current inhibition in TG neurons. SNAP was applied at
concentrations of 10 M, 30 M, 100 M, 300 M, or 1000 M under conditions of perforated patch voltage clamp; an IC50 of
370  14 M was obtained from the fit shown. D, Exemplary voltage trace of a TG neuron in control conditions and in the presence
of SNAP (500 M) during a perforated patch current-clamp recording. The traces show voltage responses to 0.125 nA current
injections (600 ms). E, Linear regression of the number of APs versus injected current (nA) was used to calculate the slope of
neuronal firing (this parameter characterizes the input– output relationship of a neuron) in the absence (control) or presence of
SNAP (100 –500 M, n  6). F, Mean data of the change in resting membrane potential (Em) following SNAP application at
concentrations of 100 M (n  7), 300 M (n  8), or 500 M (n  6)  pre-application of XE991 (3 M, n  9). G, Schematic
showing the experimental protocol for CGRP release assay and cell treatments. H, Mean data from CGRP release assay (n  3). In
all parts error bars indicate SEM and significant difference indicated by *p  0.05.
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Results
NO inhibits M-current and increases excitability of
nociceptive trigeminal neurons
Small-diameter, nociceptive neurons (mean capacitance 25  2
pF) from TG cultures displayed M-currents (mean basal
M-current amplitude 42  6 pA). To study the effect of NO on
M-current, SNAP (1 mM) was bath applied causing a slow inhi-
bition corresponding to 53  12% of M-current in 12/15 TG
neurons tested (p  0.05) (Fig. 1A,B). The M-current inhibiting
effects of SNAP were concentration dependent (Fig. 1C) with an
IC50 of 370  14 M. Inhibiting M-current in sensory neurons
from dorsal root ganglia (DRG) has previously been shown to
induce depolarization, increasing neuronal excitability and caus-
ing pain (Linley et al., 2008; Liu et al., 2008); conversely,
M-channel enhancers hyperpolarized the membrane potential of
cultured neurons (Linley et al., 2012b) and produced antinocice-
ptive effects when injected into the hindpaw of rats (Liu et al.,
2010). Thus in the present study the effect of SNAP-mediated
M-current inhibition on neuronal excitability was evaluated us-
ing perforated patch current clamp. The majority of TG neurons
(24/30) produced only one AP with or without SNAP or XE991
during current injections. However, 6/30 neurons produced
multiple APs and SNAP application (100 –500 M) increased AP
firing (n  6; Fig. 1D) and the slope of neuronal firing of these
neurons (see Materials and Methods; Fig. 1E). Application of
SNAP (100 M, 300 M, or 500 M) depolarized the neurons
causing an increase in resting membrane potential (Em) of up
to 10.0  2.0 mV (Fig. 1F). However pre-application of XE991 (3
M) almost completely abolished SNAP-induced depolarization
(Em 1.8  1.1 mV; Em for XE991 alone 4.6  1.1 mV; data
not shown). In fact the observed Em during application of
SNAP (500 M) following XE991 pre-application was signifi-
cantly smaller than Em observed during application of SNAP at
300 M or 500 M without XE991 pre-
application (p  0.05) (Fig. 1F).
M-current augmentation in cultured
DRG neurons correlates with a reduction
in CGRP release (Linley et al., 2012a). In-
creased CGRP release from trigeminal af-
ferents has been implicated in migraine
and headache pain, which could be a re-
sult of increased neuronal excitability in
response to NO signaling. To test if
SNAP-mediated inhibition of M-current
could contribute to increased CGRP release,
we studied the effect of SNAP and the
M-channel opener RTG on such release. TG
neurons were treated with SNAP (100 M),
RTG (10 M), or both and CGRP release
measured. As shown in the experimental
scheme (Fig. 1G), basal levels were first col-
lected from each sample and used for nor-
malization to correct for the number of
CGRP-positive neurons in each sample.
SNAP treatment increased CGRP release
(130  10% of control, n  3). RTG re-
duced CGRP release (80  10% of control),
while RTG prevented SNAP-mediated in-
creases (100  10% of control) (Fig. 1H).
The effects were small but consistent,
though only the SNAP-alone and RTG-
alone values were significantly different
(p  0.05). Thus, preventing M-current in-
hibition with RTG prevented the SNAP-mediated increase in CGRP
release. These data are consistent with a model whereby inhibition of
M-current by SNAP increases neuronal excitability contributing to
increased CGRP release.
Manipulating NO levels with a scavenger or by blocking NO
synthase affects M-current
To confirm that the effects of SNAP were due to NO release, an NO
scavenger, carboxy-PTIO was used in conjunction with SNAP in
perforated patch-clamp experiments. Carboxy-PTIO reacts stoichi-
ometrically with NO to inhibit its physiological effects. Incubation of
neurons with carboxy-PTIO (1 mM) prevented SNAP-mediated in-
hibition of M-current in 6/8 cells (104  6% of basal amplitude)
and, furthermore, in 2/8 neurons carboxy-PTIO increased basal
M-current (109 and 111% of basal), suggesting the inhibitory effect
of SNAP on M-current is indeed mediated by NO (Fig. 2A,B). En-
dogenous NO is generated from L-arginine by NOS enzymes. The
competitive inhibitor of NOS, L-NNA (1 mM), increased M-current
in 4/8 neurons (170  12% of basal, p  0.05), presumably via
actions through nNOS inhibition (Fig. 2C,D). This suggests that
manipulating NO levels directly affects M-current and implies there
is a level of tonic NO production that maintains partial inhibition of
M-current in TG neurons.
NO-mediated inhibition opposes oxidation-mediated
augmentation of Kv7.4 currents
Oxidative modification of cysteines in Kv7.2–7.5 augments
M-current (Gamper et al., 2006). Since NO can modulate protein
function via modification of cysteines (Lipton et al., 1993), we
hypothesized that the redox-sensitive cysteine triplet may be in-
volved in NO-sensitivity. A cell line model (CHO) transiently
expressing M-channels was used to investigate the effect of NO
on M-current. Application of SNAP (1 mM) inhibited Kv7.4 cur-
Figure 2. Manipulating NO levels with a scavenger or by blocking NO synthase affects M-current. A, Example time course of the
effect of carboxy-PTIO (1 mM) incubation before SNAP application (1 mM) on M-current in TG neurons. B, Mean data from experi-
ments as in A. C, Example time course of the effect of L-NNA (1 mM) on M-current in TG neurons. D, Mean data from experiments as
in A, expressed as percentage change in M-current from basal (n  5). Significant difference indicated by *p  0.05.
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rents (mean inhibition 32  5%, p 
0.05) (Fig. 3A,B). Washout of SNAP did
not return currents to basal levels. Ascor-
bate allows NO to combine with superox-
ide (O2
) to generate the oxidative free
radical peroxynitrite (ONOO) (Pryor
and Squadrito, 1995). Ascorbate (2 mM)
applied after SNAP caused strong aug-
mentation of Kv7.4 current, overriding the
initial inhibition by SNAP. This channel
augmentation was reversed by the selective
sulfhydryl reducing agent DTT, suggesting
that the augmenting effects of ascorbate are
due to a reversible oxidative modification.
Thus, NO and oxidative modification op-
pose one another functionally and the triple
cysteine module provides for a dynamic and
redox-dependent control of M-channel
activity.
NO site of action is cysteines 156 –158
of Kv7.4
The site of oxidative modification of Kv7
channels has been mapped to the conserved
triple cysteines within the S2–S3 linker
(amino acids 156–158 in Kv7.4) (Fig. 4A)
(Gamper et al., 2006). To determine the
contribution of these cysteines to the effects
of NO, voltage-clamp experiments were
performed in CHO cells expressing the
Kv7.4 wild-type or a mutant channel in
which all three cysteines were substituted by
alanines. Application of SNAP to wild-type
Kv7.4 caused inhibition of M-current,
whereas mutation of the triple cysteines to
alanines (CCC156–158AAA) abrogated the
inhibiting effect of NO (Fig. 4B,C). One
possible effect of NO is cysteine
S-nitrosylation (the addition of a nitrosyl
group to protein thiol groups), a modifica-
tion that can regulate protein function
(Stamler et al., 1992). A biotin switch assay
was performed to test whether SNAP can
cause S-nitrosylation of Kv7.4. CHO cells
expressing myc-tagged wild-type Kv7.4 or
CCC156–158AAA were treated with SNAP;
wild-type and mutant protein were identi-
fied on nondenaturing gels using anti-myc
antibodies. Monomeric (77 kDa) and mul-
timeric forms of wild-type Kv7.4 were
strongly biotin labeled (Fig. 4D, top), con-
sistent with S-nitrosylation. In contrast the
mutant CCC156–158AAA showed a dra-
matic reduction of biotin signal that was not
due to a lack of protein expression, since in-
put protein fractions showed high levels of
both wild-type and mutant protein (Fig. 4D,
bottom). The remaining S-nitrosylation sig-
nal may be underscored by additional cys-
teines; however, the functional data (Fig.
4B) support the conclusion that CCC156–
158 are important for Kv7 channel modula-
tion by NO.
Figure 3. Opposing effects of SNAP and oxidative modification on M-current. A, Example time course of the effect of
SNAP (1 mM), ascorbate (2 mM), and DTT (2 mM) on M-current in CHO cells transfected with a plasmid encoding Kv7.4. Bath
application of SNAP (1 mM), ascorbate (2 mM), DTT (2 mM), and XE991 (3 M) is indicated by the black bars. B, Mean data
from experiments as in A, expressed as percentage change in M-current from basal (n  5). Wash 1 followed SNAP
application, Wash 2 followed ascorbate application. Significant difference from basal indicated by *p  0.05 or
***p  0.001.
Figure 4. Mutation of cysteines 156 –158 of Kv7.4 abrogates inhibiting effect of SNAP and nitrosylation of Kv7.4. A,
Diagram indicating the position of the CCC156–158AAA residues within the S2–S3 linker. B, Example time course of the
effect of SNAP (1 mM) on Kv7.4 mutant CCC156 –158AAA. Bath application of SNAP (1 mM) and XE991 (3 M) is indicated
by the black bars. C, Mean data from experiments as in A, expressed as percentage change in M-current from basal (n  5).
Significant difference indicated by *p  0.05. D, Biotin switch assay protein samples (top) from CHO cells transfected with
pmaxGFP, myc-tagged mutant (CCC156 –158AAA), or myc-tagged Kv7.4 wild-type (Wt) were immunoprecipitated (IP)
with an anti-biotin antibody, separated on a native, nondenaturing polyacrylamide gel and blotted with anti-myc antibody
(WB). Input protein fractions from the same samples were separated on a denaturing polyacrylamide gel and the mem-
brane blotted with anti-myc antibody (bottom).
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Discussion
Since M-channels have a threshold for activation below 60 mV
and are able to remain partially open at the resting membrane
potential of a neuron, small changes in M-current magnitude can
affect neuronal excitability profoundly. SNAP-induced depolar-
ization was not observed following blockade of M-current,
suggesting that NO depolarized neurons via depression of
M-current. In large-diameter DRG neurons NO donors activate
KATP channels, reducing excitability (Kawano et al., 2009). How-
ever KATP currents are thought to play a relatively minor role in
small-diameter neurons in DRG (Du et al., 2011). In our exper-
iments NO inhibited M-current in small-diameter TG neurons,
increasing excitability and CGRP release. Thus it would seem that
KATP currents may also be relatively minor in small-diameter TG
neurons. Consistent with this notion, KATP channel openers do
not affect CGRP release in TG neurons (Ploug et al., 2012).
NO can intimately control CNS excitability and synaptic
strength by regulating potassium channel function (Steinert et
al., 2011). Endogenous NO is generated by nNOS and eNOS in
the trigeminovascular system (Ramachandran et al., 2010) and
during inflammation via iNOS (Corbett et al., 1993). Inflamma-
tory signaling alters multiple sensory neuron currents (Linley et
al., 2010) and many Gq-PCRs evoke an intracellular signaling
cascade that stimulates cleavage of phosphatidylinositol 4,5-
bisphosphate (PIP2), triggering Ca
2 release and ultimately in-
hibiting M-current (Guo and Schofield, 2002; Zaika et al., 2007;
Jia et al., 2008). Interestingly, elevated Ca 2 triggers NO produc-
tion from nNOS (Abu-Soud and Stuehr, 1993), while NOS activ-
ity is inhibited by PIP2 (Yamamoto et al., 2004). This adds an
intriguing complexity to Gq-PCR inflammatory signaling, which
is thus able to increase NO levels by two means: the removal of
PIP2-mediated inhibition and increases in Ca
2 activating
nNOS. It therefore follows that Gq-PCR signaling and NO likely
work in concert to ensure robust location- and temporal-specific
inhibition of M-current.
Studies using NOS inhibitors in migraine patients suggest that
delayed headaches are due to increased nNOS activity in the tri-
geminal system causing CGRP release (Akerman et al., 2002),
most likely due to depolarization of synaptic terminals (Durham,
2006). Our data present a contributing mechanism, whereby
M-current inhibition could mediate this increased excitability of
TG neurons. Mutations or changes in expression levels of the
M-channel genes KCNQ2 or KCNQ3 cause neuronal hyperexcit-
ability disorders, including neuropathic pain (Rose et al., 2011)
and benign familial neonatal convulsions (BFNC) (Charlier et al.,
1998; Singh et al., 1998). It was previously suggested that BFNC
and familial hemiplegic migraine cosegregate in some patients
(Terwindt et al., 1997). It would be interesting to test if
M-channel dysfunction can indeed facilitate the coincidence of
migraine and other hyperexcitability disorders.
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